Dr DIAS Alexandre

Fiche personne

Coordonnées

Centre Georges-François Leclerc
1 rue du Professeur Marion
BP 77980
21079 DIJON

03 45 34 88 06

Territoire

Bourgogne

Statut

Ingénieur/Technicien

Affiliation

Centre Georges-François Leclerc (CGFL)

Équipes/plateformes

Plateforme d'imagerie et de radiothérapie préclinique IMATHERa

Publications

External Beam Radiotherapy Primes PDL1-Targeted Radionuclide Therapy in Preclinical Colorectal Cancer Model.

Bellaye PS, Tavares A, Ladjohounlou R, Moreau M, Bernhard C, Dias A, Claron M, Froidurot L, Guillemin M, Collin B, Denat F, Truc G, Cochet A, Baude J, Mirjolet C

Int J Radiat Oncol Biol Phys. 2026 06 26;:

SPECT as a translational non-invasive method to assess occupancy of the tissue transglutaminase-2 by zampilimab in the mouse lung.

Bellaye PS, Ferrini E, Claron M, Dias A, Bonfini C, Villetti G, Capelli AM, Johnson T, Collin B, Stellari FF

Respir Res. 2026 02 12;:

Collagen-targeted PET imaging for progressive experimental lung fibrosis quantification and monitoring of efficacy of anti-fibrotic therapies.

Dias AMM, Burgy O, Moreau M, Goncalves V, Pommerolle L, Douhard R, Courteau A, Helbling A, Guillemin M, Simonet J, Oudot A, Garrido C, Bonniaud P, Goirand F, Collin B, Bellaye PS

Theranostics. 2025 01 13;15(6):2092-2103

CD206 macrophages are relevant non-invasive imaging biomarkers and therapeutic targets in experimental lung fibrosis.

Pommerolle L, Beltramo G, Biziorek L, Truchi M, Dias AMM, Dondaine L, Tanguy J, Pernet N, Goncalves V, Bouchard A, Monterrat M, Savary G, Pottier N, Ask K, Kolb MRJ, Mari B, Garrido C, Collin B, Bonniaud P, Burgy O, Goirand F, Bellaye PS

Thorax. 2024 07 20;:

Oleanolic Acid Glycosides from and : Structural Analysis and Cytotoxicity.

Nazaryan S, Bruguière A, Hovhannisyan N, Miyamoto T, Dias AMM, Bellaye PS, Collin B, Briand L, Mitaine-Offer AC

Molecules. 2023 05 25;28(11):

IL-1RAP, a Key Therapeutic Target in Cancer.

Frenay J, Bellaye PS, Oudot A, Helbling A, Petitot C, Ferrand C, Collin B, Dias AMM

Int J Mol Sci. 2022 11 29;23(23):

Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through Macrophages and Magnetic Hyperthermia.

Dias AMM, Courteau A, Bellaye PS, Kohli E, Oudot A, Doulain PE, Petitot C, Walker PM, Decréau R, Collin B

Pharmaceutics. 2022 11 5;14(11):

Lactobacillus stress protein GroEL prevents colonic inflammation.

Dias AMM, Douhard R, Hermetet F, Regimbeau M, Lopez TE, Gonzalez D, Masson S, Marcion G, Chaumonnot K, Uyanik B, Causse SZ, Rieu A, Hadi T, Basset C, Chluba J, Grober J, Guzzo J, Neiers F, Ortega-Deballon P, Demidov ON, Lirussi F, Garrido C

J Gastroenterol. 2021 Mar 29;:

Nanofitins targeting heat shock protein 110: an innovative immunotherapeutic modality in cancer.

Marcion G, Hermetet F, Neiers F, Uyanik B, Dondaine L, Dias AMM, Da Costa L, Moreau M, Bellaye PS, Collin B, Gobbo J, Briand L, Seigneuric R, Kitten O, Cinier M, Garrido C

Int J Cancer. 2021 Jan 27;:

Selecting the first chemical molecule inhibitor of HSP110 for colorectal cancer therapy.

Gozzi GJ, Gonzalez D, Boudesco C, Dias AMM, Gotthard G, Uyanik B, Dondaine L, Marcion G, Hermetet F, Denis C, Hardy L, Suzanne P, Douhard R, Jego G, Dubrez L, Demidov ON, Neiers F, Briand L, Sopková-de Oliveira Santos J, Voisin-Chiret AS, Garrido C

Cell Death Differ.. 2019 May 8;:

HSP110 translocates to the nucleus upon genotoxic chemotherapy and promotes DNA repair in colorectal cancer cells.

Causse SZ, Marcion G, Chanteloup G, Uyanik B, Boudesco C, Grigorash BB, Douhard R, Dias AMM, Dumetier B, Dondaine L, Gozzi GJ, Moussay E, Paggetti J, Mirjolet C, de Thonel A, Dubrez L, Demidov ON, Gobbo J, Garrido C

Oncogene. 2018 Dec 12;: